FDA approves Retatrutide this year?
11¢
Yes
Price history
05:13 06:11
min: 0.10 now: 0.10 max: 0.10
24h Volume
$94
Liquidity
$5K
24h Change
—
Total Volume
$573K
Order book
Price Size Total
Loading…
Market description
Retatrutide is a triple agonist hormone/peptide drug developed by Eli Lilly and currently in trial to treat obesity, fatty liver disease, type-2 diabetes, knee osteoarthritis, and …